Sir.—In his editorial on the use of ribavirin to treat respiratory syncytial virus (RSV) infections, published in the May 1988 issue of the AJDC, Ray1 poses a number of unresolved questions and invites readers to add to his list. While there is a well-known association between RSV infections and apnea, especially in young infants or those with a history of prematurity,2 it is not known if treatment with ribavirin is either warranted or effective in infants in whom apnea is the major, and sometimes the only, manifestation of infection.
Patient Reports.—Patient 1.—A 25-day-old full-term male infant who was normal at birth, except for a hemodynamically insignificant ventricular septal defect, was admitted after having had a prolonged apneic episode accompanied by profound cyanosis while at home. The infant had had two to three days of mild nasal congestion before this episode. The infant responded to bag-and-mask
ROCKNEY R. Ribavirin and Respiratory Syncytial Virus–Associated Apnea. Am J Dis Child. 1988;142(9):913. doi:10.1001/archpedi.1988.02150090011001
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: